Lockheed Martin emerges as a standout investment opportunity in the defence sector, driven by an impressive $3 billion missile defence contract and strategic dominance in key technologies. With a 12-month...
The United States has tactically lifted export restrictions on Electronic Design Automation software to China, benefiting US firms like Synopsys and Cadence. This strategic recalibration aims to manage Chinese technological...
The U.S. and Vietnam trade agreement has sent stock markets soaring, signalling a major shift in global supply chains. This isn't merely a blip; it's a formal nod to the...
The S&P 500's journey towards the ambitious 6,800 mark defies traditional wisdom, as equities rally despite a contracting M2 money supply. This shift highlights the pivotal role of robust corporate...
Exploring the AI-driven retail revolution, this report delves into how Apple and Meta are poised for growth, with Apple's privacy-centric ecosystem capturing premium partnerships and Meta's cloud-based advertising platform expanding...
Amidst swirling market rumours of the US lifting chip design export curbs to China, the reality reveals otherwise. The US maintains robust strategic export controls on crucial Electronic Design Automation...
The battle between Berkshire Hathaway and ARK Invest is not merely about stock choices but a vivid representation of two differing worldviews. Berkshire leans towards economic continuity and strong cash...
Explore the burgeoning opportunities in digital health, fintech, and urban air mobility, as we dissect the market potential of five dynamic companies. With a robust buy recommendation for HIMS and...
In the ever-evolving world of biotechnology, Moderna and Regeneron represent two contrasting tales. Moderna's cash-rich strategy must pivot beyond its COVID-19 success to future profitability, battling market scepticism. Meanwhile, Regeneron's...
Amidst a storm of elevated medical costs, regulatory scrutiny, and an antitrust probe, UnitedHealth Group's valuation tumble in 2024 offers insights into market dynamics. Despite challenges, Q1 2024 saw an...
